2007 DCIS Workshop:

Workshop Presentations

Ductal Carcinoma in Situ: Strategies for Integrating Tumor Biology and Populations Sciences Workshop
Rachel Ballard-Barbash, MD, MPH

Overview of the current definition of Ductal Carcinoma in Situ
Donald L. Weaver, MD University of Vermont

Epidemiology of DCIS
Karla Kerlikowske, MD; University of California at San Francisco

Overview of the Basic Biology: Precursors Through Invasive Disease and Future Directions
Thea Tlsty, PhD, University of California at San Francisco

Problems in the Diagnosis of Ductal Carcinoma in Situ
Stuart J. Schnitt, MD; Beth Israel Deaconess Medical Center & Harvard Medical School

Overview of Treatment
Monica Morrow, MD; Temple University School of Medicine

Predictors of DCIS Recurrence and Risk of Invasive Cancer: Overview of the Field and Current Challenges
Lawrence J. Solin, MD, FACR; University of Pennsylvania

Statistical Issues in Investigating Prognostic and Predictive Markers for DCIS
James J. Dignam, PhD; The University of Chicago

Predicting Local Invasive Recurrence After Conservative Treatment
Melvin Silverstein, MD; The USC/Norris Comprehensive Cancer Center

Impact of Pathology Practice on Outcome in Published Studies of DCIS. Recommendations for a Uniform Pathology Protocol
Michael D. Lagios; The Breast Cancer Consultation Service

Overview of State-of-the-Field and Challenges in Collaboration
Laura Esserman, MD; University of San Francisco

Approaches to Evaluation and Validation of Therapeutically Relevant Biomarkers
Annette Molinaro, PhD; Yale University School of Medicine

A Systems Approach to Predicting Drug Response
Joe W. Gray, PhD; Lawrence Berkeley National Laboratory

New Markers and Drug Therapies Being Examined in DCIS Trials
Saraswati Sukumar, PhD; Johns Hopkins University School of Medicine

Imaging: State of the Science and New Directions
Laura Liberman, MD; Memorial Sloan-Kettering Cancer Center

Meeting the Research Challenges: Update on Current Population-Level DCIS Research
Laurel Habel, PhD; Kaiser Permanente

DCIS and the Development of Diversity During Breast Cancer Evolution
Craig Allred, MD; Washington University School of Medicine

Panel: Strategies for addressing common concerns in collaborative research and how to maximize existing resources?
Graham Colditz MD, DrPH; Washington University School of Medicine
Larissa Nekhlyudov, MD, MPH, Harvard Medical School
James Dignam, Ph.D., University of Chicago

[Return to top]

Footer begins
Last modified:
29 Oct 2007
Search | Contact Us | Accessibility | Privacy Policy  
Division of Cancer Control and Population Sciences National Cancer Institute Department of Health and Human Services National Institutes of Health USA.gov: The US government's official web portal